Cargando…

Doxorubicin-loaded quaternary ammonium palmitoyl glycol chitosan polymeric nanoformulation: uptake by cells and organs

PURPOSE: This study was aimed to develop doxorubicin-loaded quaternary ammonium palmitoyl glycol chitosan (DOX–GCPQ) nanoformulation that could enable DOX delivery and noninvasive monitoring of drug accumulation and biodistribution at tumor site utilizing self-florescent property of doxorubicin. MAT...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanwal, Ummarah, Bukhari, Nadeem Irfan, Rana, Nosheen Fatima, Rehman, Mehreen, Hussain, Khalid, Abbas, Nasir, Mehmood, Arshad, Raza, Abida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302811/
https://www.ncbi.nlm.nih.gov/pubmed/30587981
http://dx.doi.org/10.2147/IJN.S176868
_version_ 1783382056704671744
author Kanwal, Ummarah
Bukhari, Nadeem Irfan
Rana, Nosheen Fatima
Rehman, Mehreen
Hussain, Khalid
Abbas, Nasir
Mehmood, Arshad
Raza, Abida
author_facet Kanwal, Ummarah
Bukhari, Nadeem Irfan
Rana, Nosheen Fatima
Rehman, Mehreen
Hussain, Khalid
Abbas, Nasir
Mehmood, Arshad
Raza, Abida
author_sort Kanwal, Ummarah
collection PubMed
description PURPOSE: This study was aimed to develop doxorubicin-loaded quaternary ammonium palmitoyl glycol chitosan (DOX–GCPQ) nanoformulation that could enable DOX delivery and noninvasive monitoring of drug accumulation and biodistribution at tumor site utilizing self-florescent property of doxorubicin. MATERIALS AND METHODS: DOX–GCPQ amphiphilic polymeric nanoformulations were prepared and optimized using artificial neural network (ANN) and characterized for surface morphology by atomic force microscopy, particle size with polydispersity index (PDI), and zeta potential by dynamic light scattering. Fourier transformed infrared (FTIR) and X-ray diffractometer studies were performed to examine drug polymer interaction. The ANN-optimized nanoformulation was investigated for in vitro release, cellular, tumor, and tissue uptake. RESULTS: The optimized DOX–GCPQ nanoformulation was anionic spherical micelles with the hydrodynamic particle size of 97.8±1.5 nm, the PDI of <0.3, the zeta potential of 28±2 mV, and the encapsulation efficiency of 80%±1.5%. Nanoformulation demonstrated a sustained release pattern over 48 h, assuming Weibull model. Fluorescence microscopy revealed higher uptake of DOX–GCPQ in human rhabdomyosarcoma (RD) cells as compared to free DOX. In vitro cytotoxicity assay indicated a significant cytotoxicity of DOX–GCPQ against RD cells as compared to DOX and blank GCPQ (P<0.05). DOX–GCPQ exhibited low IC(50) (1.7±0.404 µmol) when compared to that of DOX (3.0±0.968 µmol). In skin tumor xenografts, optical imaging revealed significantly lower DOX–GCPQ in heart and liver (P<0.05) and accumulated mainly in tumor (P<0.05) as compared to other tissues. CONCLUSION: The features of nanoformulation, ie, small particle size, sustained drug release, and enhanced cellular uptake, potential to target tumor passively coupled with the possibility of monitoring of tumor localization by optical imaging may make DOX–GCPQ an efficient nanotheranostic system.
format Online
Article
Text
id pubmed-6302811
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-63028112018-12-26 Doxorubicin-loaded quaternary ammonium palmitoyl glycol chitosan polymeric nanoformulation: uptake by cells and organs Kanwal, Ummarah Bukhari, Nadeem Irfan Rana, Nosheen Fatima Rehman, Mehreen Hussain, Khalid Abbas, Nasir Mehmood, Arshad Raza, Abida Int J Nanomedicine Original Research PURPOSE: This study was aimed to develop doxorubicin-loaded quaternary ammonium palmitoyl glycol chitosan (DOX–GCPQ) nanoformulation that could enable DOX delivery and noninvasive monitoring of drug accumulation and biodistribution at tumor site utilizing self-florescent property of doxorubicin. MATERIALS AND METHODS: DOX–GCPQ amphiphilic polymeric nanoformulations were prepared and optimized using artificial neural network (ANN) and characterized for surface morphology by atomic force microscopy, particle size with polydispersity index (PDI), and zeta potential by dynamic light scattering. Fourier transformed infrared (FTIR) and X-ray diffractometer studies were performed to examine drug polymer interaction. The ANN-optimized nanoformulation was investigated for in vitro release, cellular, tumor, and tissue uptake. RESULTS: The optimized DOX–GCPQ nanoformulation was anionic spherical micelles with the hydrodynamic particle size of 97.8±1.5 nm, the PDI of <0.3, the zeta potential of 28±2 mV, and the encapsulation efficiency of 80%±1.5%. Nanoformulation demonstrated a sustained release pattern over 48 h, assuming Weibull model. Fluorescence microscopy revealed higher uptake of DOX–GCPQ in human rhabdomyosarcoma (RD) cells as compared to free DOX. In vitro cytotoxicity assay indicated a significant cytotoxicity of DOX–GCPQ against RD cells as compared to DOX and blank GCPQ (P<0.05). DOX–GCPQ exhibited low IC(50) (1.7±0.404 µmol) when compared to that of DOX (3.0±0.968 µmol). In skin tumor xenografts, optical imaging revealed significantly lower DOX–GCPQ in heart and liver (P<0.05) and accumulated mainly in tumor (P<0.05) as compared to other tissues. CONCLUSION: The features of nanoformulation, ie, small particle size, sustained drug release, and enhanced cellular uptake, potential to target tumor passively coupled with the possibility of monitoring of tumor localization by optical imaging may make DOX–GCPQ an efficient nanotheranostic system. Dove Medical Press 2018-12-18 /pmc/articles/PMC6302811/ /pubmed/30587981 http://dx.doi.org/10.2147/IJN.S176868 Text en © 2019 Kanwal et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Kanwal, Ummarah
Bukhari, Nadeem Irfan
Rana, Nosheen Fatima
Rehman, Mehreen
Hussain, Khalid
Abbas, Nasir
Mehmood, Arshad
Raza, Abida
Doxorubicin-loaded quaternary ammonium palmitoyl glycol chitosan polymeric nanoformulation: uptake by cells and organs
title Doxorubicin-loaded quaternary ammonium palmitoyl glycol chitosan polymeric nanoformulation: uptake by cells and organs
title_full Doxorubicin-loaded quaternary ammonium palmitoyl glycol chitosan polymeric nanoformulation: uptake by cells and organs
title_fullStr Doxorubicin-loaded quaternary ammonium palmitoyl glycol chitosan polymeric nanoformulation: uptake by cells and organs
title_full_unstemmed Doxorubicin-loaded quaternary ammonium palmitoyl glycol chitosan polymeric nanoformulation: uptake by cells and organs
title_short Doxorubicin-loaded quaternary ammonium palmitoyl glycol chitosan polymeric nanoformulation: uptake by cells and organs
title_sort doxorubicin-loaded quaternary ammonium palmitoyl glycol chitosan polymeric nanoformulation: uptake by cells and organs
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302811/
https://www.ncbi.nlm.nih.gov/pubmed/30587981
http://dx.doi.org/10.2147/IJN.S176868
work_keys_str_mv AT kanwalummarah doxorubicinloadedquaternaryammoniumpalmitoylglycolchitosanpolymericnanoformulationuptakebycellsandorgans
AT bukharinadeemirfan doxorubicinloadedquaternaryammoniumpalmitoylglycolchitosanpolymericnanoformulationuptakebycellsandorgans
AT rananosheenfatima doxorubicinloadedquaternaryammoniumpalmitoylglycolchitosanpolymericnanoformulationuptakebycellsandorgans
AT rehmanmehreen doxorubicinloadedquaternaryammoniumpalmitoylglycolchitosanpolymericnanoformulationuptakebycellsandorgans
AT hussainkhalid doxorubicinloadedquaternaryammoniumpalmitoylglycolchitosanpolymericnanoformulationuptakebycellsandorgans
AT abbasnasir doxorubicinloadedquaternaryammoniumpalmitoylglycolchitosanpolymericnanoformulationuptakebycellsandorgans
AT mehmoodarshad doxorubicinloadedquaternaryammoniumpalmitoylglycolchitosanpolymericnanoformulationuptakebycellsandorgans
AT razaabida doxorubicinloadedquaternaryammoniumpalmitoylglycolchitosanpolymericnanoformulationuptakebycellsandorgans